1. Edible Mushrooms Reduce Atherosclerosis in Ldlr−/− Mice Fed a High-Fat Diet
    Sharon H Kim et al, 2019, The Journal of Nutrition CrossRef
  2. Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials
    Vaclav Vetvicka et al, 2019, Molecules CrossRef
  3. Clinical and Physiological Perspectives of β-Glucans: The Past, Present, and Future
    Khawaja Muhammad Bashir et al, 2017, International Journal of Molecular Sciences CrossRef
  4. β-glucans and cholesterol (Review)
    Petr Sima et al, 2018, International Journal of Molecular Medicine CrossRef
  5. Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents development of atherosclerosis in high-fat diet-fed apoE-deficient mice via ameliorating hyperlipidemia, pro-inflammatory mediators and oxidative responses
    Yutaro Kobayashi et al, 2018, PLOS ONE CrossRef
  6. Hypolipidemic Effects of β-Glucans, Mannans, and Fucoidans: Mechanism of Action and Their Prospects for Clinical Application
    Tatiana A. Korolenko et al, 2020, Molecules CrossRef
  7. Dietary Polycan, a β‐glucan originating from Aureobasidium pullulansSM‐2001, attenuates high‐fat‐diet‐induced intestinal barrier damage in obese mice by modulating gut microbiota dysbiosis
    Gwang‐Pyo Ko et al, 2024, Food Science & Nutrition CrossRef
  8. β-glucans: a potential source for maintaining gut microbiota and the immune system
    Ravindra Pal Singh et al, 2023, Frontiers in Nutrition CrossRef
  9. Hypolipidemic effect of XH601 on hamsters of Hyperlipidemia and its potential mechanism
    Meng-Jie Zhao et al, 2017, Lipids in Health and Disease CrossRef
  10. Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)
    Nelson Kei et al, 2023, Foods CrossRef
  11. A review of the fungal polysaccharides as natural biopolymers: Current applications and future perspective
    Sameh S. Ali et al, 2024, International Journal of Biological Macromolecules CrossRef
  12. Exploration of anti-atherosclerotic activity of 1,8-cineole through network pharmacology, molecular docking, and in vivo efficacy studies in high-fat-diet-induced atherosclerosis in hamsters
    Shreya R. Savla et al, 2024, Molecular Diversity CrossRef